Secular Growth

438 tickers in this investment thesis
Ranks this page's recent reports by score.
Applied Aerospace & Defense, Inc.
AADX·Industrials
B ★★★Hold
Current$14.96
Target$17.32
Return+15.8%
Aug 23, 2026

Applied Aerospace & Defense is a highly defensible, sole-source tollbooth for the global military modernization and commercial space supercycle, yet investors must remain intensely cautious of its bloated valuation multiple and the looming threat of a massive private equity share unlock.

Score
75
Firefly Aerospace Inc.
FLY·Industrials
B ★★★Hold
Current$24.45
Target$31.18
Return+27.5%
Aug 22, 2026

Firefly Aerospace is a rapidly scaling, vertically integrated space infrastructure powerhouse leveraging defense software and a massive $1.5 billion backlog to drive exponential growth, though investors must tolerate punishing cash burn and habitual equity dilution while awaiting orbital launch profitability.

Score
78
Warby Parker Inc.
WRBY·Healthcare
B ★★★Hold
Current$27.44
Target$30.00
Return+9.3%
Aug 22, 2026

Warby Parker is an exceptionally well-run, cash-rich disruptor steadily capturing structural share in a resilient medical-necessity market, though its severely extended valuation leaves absolutely zero room for error as it embarks on a high-risk, capital-intensive expansion into AI-enabled wearable technology.

Score
76
Cerebras Systems Inc.
CBRS·Technology
B ★★★Hold
Current$197.71
Target$277.00
Return+40.1%
Aug 22, 2026

Cerebras commands the hyper-growth AI inference market with a historic $25.4 billion backlog and revolutionary wafer-scale architecture, though its 45x forward multiple and intense Nvidia competition demand patience.

Score
76
Privia Health Group, Inc.
PRVA·Healthcare
B ★★★Hold
Current$21.50
Target$26.00
Return+20.9%
Aug 22, 2026

Privia Health operates an elite, capital-light tollbooth bridging independent physicians into the profitable future of value-based care, though investors must tolerate exceptionally high stock-based compensation and near-term Medicare Advantage turbulence.

Score
81
IDEAYA Biosciences, Inc.
IDYA·Healthcare
B ★★★Hold
Current$39.67
Target$51.55
Return+29.9%
Aug 22, 2026

IDEAYA is a uniquely de-risked, cash-rich precision oncology leader poised to dominate the massive MTAP-deleted tumor market, though investors must remain hyper-vigilant regarding the inherently high relative valuation and strict reliance on forthcoming FDA regulatory verdicts.

Score
83
Ondas Inc.
ONDS·Technology
C ★★Sell
Current$8.38
Aug 22, 2026

Ondas combines Palantir-integrated autonomous defense, rapid growth and a $757M backlog, but integrating six acquisitions and relentless dilution make the stock unattractive until those risks ease.

Score
69
CoreWeave, Inc.
CRWV·Technology
B ★★★Hold
Current$92.68
Target$155.60
Return+67.9%
Aug 21, 2026

CoreWeave is the deeply undervalued pure-play architect of the generative AI infrastructure boom, though investors must possess the stomach to endure a highly leveraged balance sheet built upon unrelenting capital expenditures.

Score
80
Sociedad Química y Minera de Chile S.A.
SQM·Materials
A ★★★★Buy
Current$75.38
Target$105.00
Return+39.3%
Aug 21, 2026

SQM stands as an unassailable, highly profitable force in the global energy transition, trading at a steep discount to peers, though investors must continuously navigate the complex 2031 Codelco ownership transition and persistent lithium spot price volatility.

Score
94
James Hardie Industries plc
JHX·Materials
B ★★★Hold
Current$29.29
Target$34.50
Return+17.8%
Aug 21, 2026

James Hardie is an unstoppable, wide-moat compounder riding a decades-long structural transition toward premium building materials, though investors must accept a fully priced valuation and a permanent 35% free cash flow tax tied to legacy asbestos liabilities.

Score
75
Keysight Technologies, Inc.
KEYS·Technology
B ★★★Hold
Current$314.75
Target$349.87
Return+11.2%
Aug 21, 2026

Keysight is an elite, cash-gushing tollbooth for the global AI and 6G technology supercycle, fortified by deep software integration and an impenetrable moat, though its priced-for-perfection valuation demands immense caution for new capital deployment.

Score
76
Amer Sports, Inc.
AS·Consumer Discretionary
B ★★★Hold
Current$34.03
Target$41.86
Return+23.0%
Aug 21, 2026

Amer Sports is executing a flawless, high-margin direct-to-consumer revolution fueled by the explosive global demand for Arc'teryx and Salomon, yet investors must remain vigilant regarding its vulnerability to severe geopolitical tariff shocks and a stretched valuation multiple.

Score
78